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red blood cells, lymphocytes, fibroblasts, histiocytes. The signs of
tumor cell death by activation of apoptosis were observed: shrink-
age and reduction in cell volume, chromatin hyper condensation,
fragmentation of organelles and nucleus, a large amount of
coarse bundles of microfilaments, the presence of apoptotic cells.
Tumor tissue was infiltrated predominantly with CD3 and CD161a
cells, CD45a indicators decreased by 3–4.5 times.
The analysis of antitumor effect in breast cancer patients
depending on factors of energy processes inhibition revealed that
complete tumor regression only in combination with ATP
occurred in 14.2%, and D-in 18.8%, partial regression using ATP
was 71–5%, D – 62.5%. Tumor progression was not observed.
Conclusion: Modulating abnormalities in energy metabolism
due to metabolic acidosis of tumor microenvironment on the
background of systemic chemotherapy, one can achieve activa-
tion of additional pathogenetic mechanisms of inhibition of
tumor growth and tumor cell death. It is necessary to emphasize
the importance of the further search for factors of pathogenetic
mechanisms and therapy of the influence on the tumor, including
the modulation of acidosis of peritumoraly area that opens up
new perspectives in solving this problem.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.094
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Non-small cell lung cancer (NSCLC) is characterized by multi-
ple genetic alterations such as loss of heterozygosity (LOH),
microsatellite instability (MSI), promoter hypermethylation and
changes of miRNA expression. According to a field cancerization
(FC) phenomenon the adjacent histologically normal tissue plays
a role in tumor progression by triggering the transformation
process.
The aim of the study was the analysis of genetic alterations in
tumor and adjacent tissue to determine the FC size and to reveal
associations with clinico-morphological features of patients.
The study group included 135 patients with NSCLC. From each
patient 4 FFPE samples were analyzed: tumor, adjacent normal
lung tissue at 2, 5, 10 cm. LOH/MSI analysis was evaluated by
PCR using 7 microsatellite loci. Promoter hypermethylation in
genes RASSF1A FHIT, DAPK1, CDH1, CD44, TIMP3, MGMT was
investigated by methyl-sensitive PCR. The expression levels of
miRNAs let-7a, miR-155, miR-205 were measured by real-time
PCR.
Our results demonstrated that LOH/MSI occurs only in tumor
while promoter hypermethylation occurs also in adjacent tissue
at 2, 5 cm, but not at 10 cm. The downregulation of let-7a,
miR-155 in adjacent tissue is lower than in tumor. The levels of
investigated miRNAs in adjacent tissue vary depending on tumor
differentiation – in patients with differentiated tumors it is higher
than in the group with poorly differentiated tumors.
We postulate that FC size in NSCLC is at least 5 cm from tumor
and includes only epigenetic but not structural (LOH/MSI)
alterations. The evaluation of epigenetic changes in adjacent
tissue (e.g., surgical margins) can potentially be used for
postsurgical prognosis.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.095
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Cervical cancer is one of the most common female malignan-
cies with incidence of 19.7 per 100,000 population in Russia in
2011 (Davydov, Aksel et al., 2011). Over 6000 women in Russia
die of cervical cancer annually.
The cervical cancer incidence shows a tendency towards
increasing rates among young women (Chissov, 2009). Tomsk
region has been found to be the territory of increased cancer risk
for cervical cancer. The age-standardized incidence rate is 1.87
times higher in Tomsk region than in Russia, being 20.40/0000
(Pisareva, Odintsova et al., 2012). The highest incidence of cervical
cancer is observed in women aged 15–39 years (Churuksaeva,
Kolomiets, Shpileva, 2012). The causal role of human papillo-
mavirus infections in cervical cancer has been documented
beyond reasonable doubt. Prevention of exposure to high risk
HPV types by vaccination may prove to be the most efficient
and logistically feasible preventive intervention for cervical
cancer.
Epidemiological studies conducted at the Tomsk Cancer
Research Institute have shown that the median age of patients
with cervical intraepithelial neoplasia and cervical cancer is
39.9 ± 8.5, and 89.5% of women are HPV-positive. Prevalence of
high-grade squamous intraepithelial lesion (H-SIL) peaks
between ages 25 years and 30 years.
The predominant HPV type in screened women of Tomsk
region as well as worldwide is HPV-16, reaching peak incidence
in women aged 36–40 years (74%). In the older age group (from
51 to 60 years), HPV-18 is associated with 25% of cervical cancer
cases. High prevalence of HPV-31 has been found in women under
the age of 45 years with an incidence peak (17%) in the age group
620 years.
The geographical widespread data on HPV type-distribution
are essential for estimating the impact of vaccines on cervical
cancer and cervical screening programs. Immunization against
HPV for young women aged between 9 and 26 years, with a pre-
dominant age cohort 11–13 years, was introduced in Tomsk
region in 2010. The aim of the HPV immunization program is to
protect females before they reach an age when the risk of HPV
infection increases. A total of 627 girls were vaccinated, and
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1653 doses of vaccines were injected. The three- dose schedule
was given to 414 (66%) girls and 2-dose schedule to 198 (31.6%)
girls. Vaccine safety assessment was carried out. Adverse effects
were observed in 9.6% of cases and were mainly characterized by
dizziness and pain at the injection site. Vaccination was well
tolerated.
When calculating socio-economic feasibility of the proposed
technology , not only the economic damage caused by the high
mortality of women from cervical cancer, but also the cost for
treatment of precancerous cervical lesions were taken into
account, as out of 25 women with undetected CINII-III, 10 will
develop cervical cancer. There have been calculated the esti-
mated damage from cervical cancer in the Tomsk region, which
takes into account not only the cost of diagnosis and treatment
of cervical pre-cancer, but also losses associated with temporary
permanent disabilities (social benefits, including disability pen-
sion before the age of 55 years). Calculations show that the total
economic damage caused by the management of patients with
cervical cancer, can be from 20 to 40 mln. rubles per year.
Thus, primary prevention of cervical cancer, taking into
account the prevalence of HPV infection and economic impact
of cervical cancer can be considered as an effective technology
for public health that will allow preservation of not only
reproductive but also employment potential of women of Tomsk
region.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.096
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Background: Myelofibrosis with myeloid metaplasia is chronic
mieloproliferative disease with ineffective erythropoiesis,
dysplastic-megakaryocyte hyperplasia, and an increase in the
ratio of immature granulocytes to total granulocytes. The
incidence rate is 3.7–5.7 per 100,000 and the median survival is
estimated to be between three and six years. The pathogenesis
of myelofibrosis might be explained, in part, by a somatic point
mutation on exon 14 (V617F) of the JAK2 kinase gene that is
located on chromosome 9p24. However, mechanisms of regula-
tion of microenvironment in bone marrow fibrosis are not clear.
Considered that main producents of pro-fibrotic factors are the
megakaryocytes and the macrophages. In this study we investi-
gated influence of platelet factors on the cellular characteristics
of the macrophages with oncogenic mutation JAK2 V617F.
Materials and Methods: THP-1 cell line wasmodified by lentivi-
ral modification. Two cell lines established: one with expression
of JAK2 with oncogenic mutation JAK2 V617F, another wild type
JAK2. Cells were cultured in RPMI-1640 containing 0.1% gentam-
icin, 1% l-glutamine and 10% fetal bovine serum (FBS) or 5%,
10% and 15% platelet lysate (PL). Cell lines were differentiated into
the macrophages using 50 ng/ml phorbolmyristate acetate (PMA).
Level of expression transforming growth factor b (TGFb), galectin-
3, matrix metalloproteinases (MMP) 2, 9, 12, 13 and tissue inhibi-
tors of matrix metalloproteinase (TIMP) accessed by specific RT-
qPCR.
Results: We observed increased expression level of galectin-3,
MMP-2, MMP-13 and TIMP-3 in JAK2 V617F expressing macro-
phages cultured with 10% FBS compare to ones with WT JAK2.
Also macrophages containing mutation JAK2 V617F has increased
level of expression of MMP-2, TIMP-3 and TIMP-4 when cultured
with 10% platelet lysate. Also, cell line containing mutation
JAK2 V617F has increased levels of expression of MMP-12 for cells
cultured with 15% PL. We did not observe any significant
difference in expression of TGFb, MMP-9, TIMP-1 and -2.
Conclusion: Increased levels of expression of galectin-3, MMP-
12 and -13 suggest that platelet factors induce macrophages with
JAK2 V617F mutation to release of profibrotic factors. On the other
hand, increase of antifibrotic MMP-2 and TIMP-3 revealing
complex nature of melofibrosis development and need to be
analyzed further.
This study confirms the idea of interaction between macro-
phages and platelets in pathogenesis of primary myelofibrosis.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.097
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High dose IL-2 (HD IL-2) has been extensively used as an
immunotherapy against metastatic melanoma However, why
HD IL-2 is effective only in a subset of patients and whether pre-
dictive biomarkers, before or early during the course of therapy,
can be used to improve response rates remain unresolved. In
addition, it has been found that IL-2 therapy potently expands
CD4+CD25+Foxp3+ T-regulatory cells (Tregs) but how Treg cell
levels, phenotype, and function change and whether specific sub-
sets of Tregs are activated and expanded during HD IL-2 therapy is
remain unclear. In this study, we performed comprehensive
multi-parameter FACS analysis of patient blood before and two
days after the last bolus of IL-2 infusion during cycle 1 of HD
IL-2 therapy. Two lymphocyte subsets were found to expand the
most during the first cycle of IL-2 therapy: CD4+CD25+Foxp3+
Tregs expressing an activation marker, inducible costimulator
(ICOS), and CD3-CD56hiCD16loPerforin+ NK cells. ICOS+ Tregs
expressed significantly higher levels of CD25, Foxp3 and had a
more activated phenotype than ICOS Tregs as indicated by lower
levels of CD45RA and CD127 expression. Further phenotypic char-
acterization revealed a more suppressive phenotype on ICOS+
Treg with higher expression levels of CD39, CD73, and TGF-b/
LAP than ICOS Treg. ICOS+ Tregs were also the predominant
Treg cells that secreted IL-10 and have potent T-cell suppressor
function. Majority of ICOS+ Tregs from HD IL-2-treated patients
were Ki67+ and exhibited an enhanced proliferative response to
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